Policy● Neutral for Indian equities
What is inside your supplement? Maharashtra FDA plans wider scrutiny
The brief
- Maharashtra FDA plans wider scrutiny of supplement contents, labelling, consumption and sales
- Tighter scrutiny could affect supplement makers and sellers in Maharashtra